SEARCH

SEARCH BY CITATION

References

  • Acquas E., Marrocu P., Pisanu A., Cadoni C., Zernig G., Saria A. and Di Chiara G. (2001) Intravenous administration of ecstasy (3,4-methylenedioxymethamphetamine) enhances cortical and striatal acetylcholine release in vivo. Eur. J. Pharmacol. 418, 207211.
  • Atkins C. M., Selcher J. C., Petraitis J. J., Trzaskos J. M. and Sweatt J. D. (1998) The MAPK cascade is required for mammalian associative learning. Nat. Neurosci. 1, 602609.
  • Berhow M. T., Hiroi N. and Nestler E. J. (1996) Regulation of ERK (extracellular signal regulated kinase), part of the neurotrophin signal transduction cascade, in the rat mesolimbic dopamine system by chronic exposure to morphine or cocaine. J. Neurosci. 16, 47074715.
  • Cadoni C., Solinas M., Pisanu A., Zernig G., Acquas E. and Di Chiara G. (2005) Effect of 3,4-methylenedioxymethamphetamine (MDMA, ‘ecstasy’) on dopamine transmission in the nucleus accumbens shell and core. Brain Res. 1055, 143148.
  • Colado M. I., O’Shea E. and Green A. R. (2004) Acute and long-term effects of MDMA on cerebral dopamine biochemistry and function. Psychopharmacology 173, 249263.
  • Crane A. M. and Porrino L. J. (1989) Adaptation of the quantitative 2-[14C]-deoxyglucose method for use in freely moving rats. Brain Res. 499, 8792.
  • Daniela E., Brennan K., Gittings D., Hely L. and Schenk S. (2004) Effect of SCH 23390 on (+/−)-3,4-methylenedioxymethamphetamine hyperactivity and self-administration in rats. Pharmacol. Biochem. Behav. 77, 745750.
  • Di Chiara G. (1999) Drug addiction as dopamine-dependent associative learning disorder. Eur. J. Pharmacol. 375, 1330.
  • Di Chiara G. (2002) Nucleus accumbens shell and core dopamine: differential role in behavior and addiction. Eur. J. Pharmacol. 137, 75114.
  • Di Chiara G., Tanda G., Frau R. and Carboni E. (1993) On the preferential release of dopamine in the nucleus accumbens by amphetamine: further evidence obtained by vertically implanted concentric dialysis probes. Psychopharmacology 112, 398402.
  • Dragunow M., Robertson G. S., Faull R. L., Robertson H. A. and Jansen K. (1990) D2 dopamine receptor antagonists induce fos and related proteins in rat striatal neurons. Neuroscience 37, 287294.
  • Fantegrossi W. E., Ullrich T., Rice K. C., Woods J. H. and Winger G. (2002) 3,4-Methylenedioxymethamphetamine (MDMA, ‘ecstasy’) and its stereoisomers as reinforcers in rhesus monkeys: serotonergic involvement. Psychopharmacology 161, 356364.
  • Fienberg A. A., Hiroi N., Mermelstein P. G. et al. (1998) DARPP-32: regulator of the efficacy of dopaminergic neurotransmission. Science 281, 838842.
  • Gifford A. N., Minabe Y., Toor A., Wang R. Y. and Ashby C. R. Jr (1996) Examination of the action of 3,4-methylenedioxymethamphetamine on rat A10 dopamine neurons. Synapse 23, 5257.
  • Gudelsky G. A. and Nash J. F. (1996) Carrier-mediated release of serotonin by 3,4-methylenedioxymethamphetamine: implications for serotonin-dopamine interactions. J. Neurochem. 66, 243249.
  • Gudelsky G. A., Yamamoto B. K. and Nash J. F. (1994) Potentiation of 3,4-methylenedioxymethamphetamine-induced dopamine release and serotonin neurotoxicity by 5-HT2 receptor agonists. Eur. J. Pharmacol. 264, 325330.
  • Hiramatsu M. and Cho A. K. (1990) Enantiomeric differences in the effects of 3,4-methylenedioxymethamphetamine on extracellular monoamines and metabolites in the striatum of freely-moving rats: an in vivo microdialysis study. Neuropharmacology 29, 269275.
  • Johnson M. P., Hoffman A. J. and Nichols D. E. (1986) Effects of the enantiomers of MDA, MDMA and related analogues on [3H]serotonin and [3H]dopamine release from superfused rat brain slices. Eur. J. Pharmacol. 132, 269276.
  • Kelland M. D., Freeman A. S. and Chiodo L. A. (1989) (+/−)-3,4-Methylenedioxymethamphetamine-induced changes in the basal activity and pharmacological responsiveness of nigrostriatal dopamine neurons. Eur. J. Pharmacol. 169, 1121.
  • Konradi C., Cole R. L., Heckers S. and Hyman S. E. (1994) Amphetamine regulates gene expression in rat striatum via transcription factor CREB. J. Neurosci. 14, 56235634.
  • Lecca D., Cacciapaglia F., Valentini V., Gronli J., Spiga S. and Di Chiara G. (2006a) Preferential increase of extracellular dopamine in the rat nucleus accumbens shell as compared to that in the core during acquisition and maintenance of intravenous nicotine self-administration. Psychopharmacology 184, 435446.
  • Lecca D., Cacciapaglia F., Valentini V., Acquas E. and Di Chiara G. (2006b) Differential neurochemical and behavioral adaptation to cocaine after response contingent and non-contingent exposure in the rat. Psychopharmacology, Epub ahead of print.
  • Matthews R. T., Champney T. H. and Frye G. D. (1989) Effects of (+−)3,4-methylenedioxymethamphetamine (MDMA) on brain dopaminergic activity in rats. Pharmacol. Biochem. Behav. 33, 741747.
  • McQuade R. D., Duffy R. A., Anderson C. C., Crosby G., Coffin V. L., Chipkin R. E. and Barnett A. (1991) [3H]SCH 39166, a new D1-selective radioligand: in vitro and in vivo binding analyses. J Neurochem. 57, 20012010.
  • Mechan A. O., Esteban B., O’Shea E., Elliott J. M., Colado M. I. and Green A. R. (2002) The pharmacology of the acute hyperthermic response that follows administration of 3,4-methylenedioxymethamphetamine (MDMA, ‘ecstasy’) to rats. Br. J. Pharmacol. 135, 170180.
  • Morelli M., Carboni E., Cozzolino A., Tanda G. L., Pinna A. and Di Chiara G. (1992) Combined microdialysis and fos immunohistochemistry for the estimation of dopamine neurotransmission in the rat caudate-putamen. J. Neurochem. 59, 11581160.
  • Paxinos G. and Watson C. (1998) The rat brain in stereotaxic coordinates. Academic Press, Sydney.
  • Pontieri F. E., Tanda G. and Di Chiara G. (1995) Intravenous cocaine, morphine, and amphetamine preferentially increase extracellular dopamine in the ‘shell’ as compared with the ‘core’ of the rat nucleus accumbens. Proc. Natl Acad. Sci. USA 92, 12 30412 308.
  • Pontieri F. E., Tanda G., Orzi F. and Di Chiara G. (1996) Effects of nicotine on the nucleus accumbens and similarity to those of addictive drugs. Nature 382, 255257.
  • Ratzenboeck E., Saria A., Kriechbaum N. and Zernig G. (2001) Reinforcing effects of MDMA (‘ecstasy’) in drug-naive and cocaine-trained rats. Pharmacology 62, 138144.
  • Robertson G. S., Vincent S. R. and Fibiger H. C. (1992) D1 and D2 dopamine receptors differentially regulate c-fos expression in striatonigral and striatopallidal neurons. Neuroscience 49, 285296.
  • Sabol K. E. and Seiden L. S. (1998) Reserpine attenuates D-amphetamine and MDMA-induced transmitter release in vivo: a consideration of dose, core temperature and dopamine synthesis. Brain Res. 806, 6978.
  • Salzmann J., Marie-Claire C., Le Guen S., Roques B. P. and Noble F. (2003) Importance of ERK activation in behavioral and biochemical effects induced by MDMA in mice. Br. J. Pharmacol. 140, 831828.
  • Schafe G. E., Atkins C. M., Swank M. W., Bauer E. P., Sweatt J. D. and LeDoux J. E. (2000) Activation of ERK/MAP kinase in the amygdala is required for memory consolidation of pavlovian fear conditioning. J. Neurosci. 20, 81778187.
  • Schenk S., Gittings D., Johnstone M. and Daniela E. (2003) Development, maintenance and temporal pattern of self-administration maintained by ecstasy (MDMA) in rats. Psychopharmacology 169, 2127.
  • Schmidt C. J. (1987) Acute administration of methylenedioxymethamphetamine: comparison with the neurochemical effects of its N-desmethyl and N-ethyl analogs. Eur. J. Pharmacol. 136, 8188.
  • Schmidt C. J., Levin J. A. and Lovenberg W. (1987) In vitro and in vivo neurochemical effects of methylenedioxymethamphetamine on striatal monoaminergic systems in the rat brain. Biochem. Pharmacol. 36, 747755.
  • Sgambato V., Pages C., Rogard M., Besson M. J. and Caboche J. (1998) Extracellular signal-regulated kinase (ERK) controls immediate early gene induction on corticostriatal stimulation. J. Neurosci. 18, 88148825.
  • Shankaran M. and Gudelsky G. A. (1998) Effect of 3,4-methylenedioxymethamphetamine (MDMA) on hippocampal dopamine and serotonin. Pharmacol. Biochem. Behav. 61, 361366.
  • Sweatt J. D. (2001) The neuronal MAP kinase cascade: a biochemical signal integration system subserving synaptic plasticity and memory. J. Neurochem. 76, 110.
  • Sweatt J. D. (2004) Mitogen-activated protein kinases in synaptic plasticity and memory. Curr. Opin. Neurobiol. 14, 311317.
  • Tanda G., Pontieri F. E. and Di Chiara G. (1997) Cannabinoid and heroin activation of mesolimbic dopamine transmission by a common mu1 opioid receptor mechanism. Science 276, 20482050.
  • Valjent E., Corvol J. C., Pages C., Besson M. J., Maldonado R. and Caboche J. (2000) Involvement of the extracellular signal-regulated kinase cascade for cocaine-rewarding properties. J. Neurosci. 20, 87018709.
  • Valjent E., Pages C., Rogard M., Besson M. J., Maldonado R. and Caboche J. (2001a) Delta 9-tetrahydrocannabinol-induced MAPK/ERK and Elk-1 activation in vivo depends on dopaminergic transmission. Eur. J. Neurosci. 14, 342352.
  • Valjent E., Caboche J. and Vanhoutte P. (2001b) Mitogen-activated protein kinase/extracellular signal-regulated kinase induced gene regulation in brain: a molecular substrate for learning and memory? Mol. Neurobiol. 23, 8399.
  • Valjent E., Pages C., Herve D., Girault J. A. and Caboche J. (2004) Addictive and non-addictive drugs induce distinct and specific patterns of ERK activation in mouse brain, Eur. J. Neurosci. 19, 18261836.
  • Wakonigg G., Sturm K., Saria A. and Zernig G. (2003) Methylenedioxymethamphetamine (MDMA, ‘ecstasy’) serves as a robust positive reinforcer in a rat runway procedure. Pharmacology 69, 180182.
  • Yamamoto B. K. and Spanos L. J. (1988) The acute effects of methylenedioxymethamphetamine on dopamine release in the awake-behaving rat. Eur. J. Pharmacol. 148, 195203.
  • Ying S. W., Futter M., Rosenblum K., Webber M. J., Hunt S. P., Bliss T. V. and Bramham C. R. (2002) Brain-derived neurotrophic factor induces long-term potentiation in intact adult hippocampus: requirement for ERK activation coupled to CREB and upregulation of Arc synthesis. J. Neurosci. 22, 15321540.